Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy

International Journal of Dermatology

Volumn 47, Issue 9, 2008, Pages 918-925

  Geusau, Alexandra ^a   Dunkler, Daniela ^a   Messeritsch, Eva ^a   Sandor, Nicolaus ^a   Heidler, Gudrun ^a   Rödler, Suzanne ^a   Ankersmit, Jan ^a   Zuckermann, Andreas ^a   Tschachler, Erwin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INOLIMOMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGE; ARTICLE; AUSTRALIA; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GEOGRAPHY; GRAFT RECIPIENT; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRECANCER; RISK FACTOR; SKIN BIOPSY; SKIN CANCER; SKIN CARE; SKIN SURGERY; SUN EXPOSURE; TIME;

AGE DISTRIBUTION; AGED; AUSTRIA; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 50149096843     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03711.x     Document Type: Article

References (39)

1. Berg D, Otley CC. Skin cancer in organ transplant recipients, epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1.
2. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. New Engl J Med 2003; 348: 1681.
3. Boukamp P. Non-melanoma skin cancer what drives tumour development and progression? Carcinogenesis 2005; 26: 1657.
4. Ichihashi M, Ueda M, Budiyanto A, et al. UV-induced skin damage. Toxicology 2003; 189: 21.
5. Vink AA, Moodycliffe AM, Shreedhar V, et al. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane primidine dimers. Proc Natl Acad Sci USA 1997; 94: 5255.
6. Otley CC, Coldiron BM, Stasko T, et al. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001; 137: 459.
7. Hojo M, Morimoto T, Malluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397: 530.
8. O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UV A light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871.
9. Herman M, Weinstein T, Korzets A, et al. Effects of cyclosporine A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med 2001; 137: 14.
10. Caillard S, Dharnidharka V, Agodoa L, et al. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplant 2005; 15: 1233.
11. Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 222.
12. Bustami RT, Ojo AO, Wolfe RA, et al. Immunosuppression and the risk of posttransplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant 2004; 4: 87.
13. Sheil AG. Development of malignancy following renal transplantation in Australia and New Zealand. Transplant Proc 1992; 24: 1275.
14. Espana A, Martinez-Gonzalez MA, Garcia-Granero M, et al. A prospective study of incident nonmelanoma skin cancer in heart transplant recipients. J Invest Dermatol 2000; 115: 1158.
15. Bouwes-Bavinck JN, Nermeek B, van der Woulde F, et al. Relation between skin cancer and HLA antigens in renal transplant recipients. N Engl J Med 1991; 325: 8438.
16. Stockfleth E, Nindl I, Sterry W, et al. Human Papillomaviruses in transplant-associated skin cancers. Dermatol Surg 2004; 30: 604.
17. Iftner A, Klug S, Garbe C, et al. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res 2003; 63: 7515.
18. Meyer T, Arndt R, Nindl I, et al. Association of human papillomavirus infection with cutaneous tumours in immunosuppressed patients. Transpl Int 2003; 16: 146.
19. Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506.
20. Harwood CA, Proby CM, McGregor JM, et al. Clinicopathologic features of skin cancer in organ transplant recipients: A retrospective case-control study. J Am Acad Dermatol 2006; 54: 290.
21. Adamson R, Obispo E, Dychter S et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: A single-center study. Tranplant Proceed 1998; 30: 1124.
22. Veness MJ, Quinn DI, Ong CS, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation. Cancer 1999; 85: 1758.
23. Pollard JD, Hanasono MM, Mikulec AA, et al. Head and neck cancer in cardiothoracic transplant recipients. Laryngoscope 2000; 110: 1257.
24. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177.
25. Caforio ALP, Fortina AB, Piaserico S, et al. Skin cancer in heart transplant recipients. Circulation 2000; 102: S222.
26. Fortina AB, Caforio AL, Piaserico S, et al. Skin cancer in heart transplant recipients: Frequency and risk factor analysis. J Heart Lung Transplant 2000; 19: 249.
27. Ong C, Keogh AM, Kossard S, et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40: 27.
28. Ulrich C, Schmook T, Sachse MM, et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30: 622.
29. Naldi L, Fortina AB, Lovati S, et al. Risk of nonmelanoma skin cancer in italian organ transplant recipients. A registry-based study. Transplantation 2000; 70: 1479.
30. Gjersvik P, Hansen S, Moller B, et al. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients? Transpl Int 2000; 13: S380.
31. Euvrard S, Kanitakis J, Decullier E, et al. Subsequent skin cancers in kidney and heart transplantat recipients after the first squamous cell carcinoma. Transplantation 2006; 81: 1093.
32. Lindelöf B, Dal H, Wolk K, et al. Cutaneous squamous cell carcinoma in organ transplant recipients. Arch Dermatol 2005; 141: 447.
33. Fuente MJ, Sabat M, Roca J, et al. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149: 1221.
34. Bouwes-Bavinck J, Hardie D, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation 1996; 61: 715.
35. Moosa MR, Gralla J. Skin cancer in renal allograft recipients - experience in different ethnic groups residing in the same geographical region. Clin Transplant 2005; 19: 735.
36. Lindelöf B, Granath F, Dal H, et al. Sun habits in kidney transplant recipients with skin cancer: A case-control study of possible causative factors. Acta Dermatol Venereol 2003; 83: 189.
37. Fortina AB, Piaserico S, Caforio ALP, et al. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004; 140: 1079.
38. Dantal J, Hourmant M, Cantarovich D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporine regimens. Lancet 1998; 351: 623.
39. Lampros T, Cobanoglu A, Parker F, et al. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant 1998; 17: 586.